Rohan Paul (@rohanpaul_ai)T2·Agents
58 pts
Y Combinator-backed startup Helios has introduced a needle-free at-home blood collection device that measures over 1,000 protein biomarkers from a single drop of blood, far beyond the roughly 20 markers in a routine checkup panel. An AI agent then interprets the results, flags rising disease risks and offers personalized guidance; the product is currently in waitlist stage.